치아발육시기에서의 RANKL 및 OPG의 발현 양상
The expression patterns of RANKL and OPG in murinetooth eruption
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
치아의 맹출은 치아기 (dental organ)와 치조골의 세포와 연관된 매우 복잡한 과정이다. 우선 치아 맹출이 일어나기 전에 파골세포가 치낭으로 집결하게 된다. 이러한 치낭의 역할은 파골세포와 조골세포의 상호작용으로 이루어 지는 골개조와 밀접한 관련이 있는데, 이는 치아 맹출과 연관된 많은 유전자들이 치낭에서 발현되기 때문이다. RANKL는 TNF ligand family로써 조골세포에 존재하며 파골세포의 형성 및 전구세포로 부터의 활성화를 유도한다. 이러한 RANKL는 OPG에 의해 그 작용이 억제되며 RANKL와 OPG의 상대적인 비율이 파골세포의 형성에 영향을 미친다. 또한 Runx2 유전자의 변이는 조골세포의 분화와 활성에 차질을 가져오고 결국 RANKL/OPG pathway를 통해 파골세포 형성에 영향을 줄 수 있다. 치아의 발육 및 맹출에 미치는 RANKL 및 OPG의 영향을 알아보고 Runx2와의 연관성을 알아보기 위해 in situ hybridization 방법으로 태생 1, 3, 5, 7, 9, 11일된 쥐의 하악 및 제1대구치를 사용하여 실험을 실시한 결과 RANKL, OPG, Runx2의 mRNA가 태생 1일부터 11일까지 치낭 및 치아주위조직에 특성있게 나타났다. 이중 태생 5일에서 9일 사이에 RANKL 및 Runx2는 치아의 교합면측과 하방 치조골 부위의 발현이 강하게 나타난 반면 OPG는 약한 발현을 보였다. 이는 또한 파골세포의 활성부위를 알아보기 위해 TRAP염색을 실시하여 태생 5일에서 9일 사이에 최대의 활성화를 나타낸 결과와 연관성 있게 나타났다. RANKL, OPG, Runx2의 특성있는 발현양상들을 종합해 볼때, 치아 맹출은 치낭, 치아기, 치조골 사이의 상호 작용을 통해 이루어 지며, 이는 치낭이 치아 맹출에 있어서 매우 중요하다는 것을 의미한다. 또한, 이러한 유전자들 (RANKL, OPG, Runx2) 이 치아의 맹출에 중요한 역할을 하는 것으로 사료된다.
Abstract
Tooth eruption is a complex and tightly regulated process that involves cells of the tooth organ and the surrounding alveolus. Osteoclast precursors must be recruited into the dental follicle prior to the onset of eruption. This function of dental follicle may be regarded as the ability of bone remodeling characterized by the interaction of osteoclasts and osteoblasts. This is because tooth eruption is a localized event in which many of the genes required for eruption are expressed in the dental follicle. RANKL is a membrane-bound protein that is a member of the TNF ligand family, which is present on bone marrow stromal cells and osteoblasts, and induces osteoclast formation and activation from precursor cell. The biologic effect of RANKL is inhibited by OPG and, in bone, the relative ratio of RANKL and OPG modulates osteoclastogenesis. To evaluate the roles of RANKL and OPG in tooth eruption and the relations with the expression pattern of Runx2, in situ hybridization was performed with mandibles of mice at postnatal stage 1, 3, 5, 7, 9 and 11. mRNA of RANKL, OPG, and Runx2 are expressed in dental follicle and surrounding tissue from P1 to 11. To determine the sites of osteoclastic activity during tooth eruption, mandibles were dissected. Peak osteoclastic activity in alveolar bone along the occlusal and basal regions was observed from P5 to 9, with osteoclasts in these regions being large and strongly TRAP-positive. The specific spatio-temporal expression patterns of RANKL, OPG, and Runx2 in our study suggest that tooth eruption could be progressed through the interactions of molecular signaling among dental follicle, dental organ and alveolar bone, furthermore it means that dental follicle is quite important in tooth eruption. In addition, it indicates that these genes (RANKL, OPG, and Runx2) play critical roles in tooth eruption.
참고문헌 (33)
- Wise GE, "Cellular, molecular, and genetic determinants of tooth eruption.", 13(4), pp.323~334 (2002)
- Heinrich J, "CSF-1, RANKL and OPG regulate osteoclastogenesis during murine tooth eruption.", 50, pp.897~906 (2005)
- Marks SC, "Regional control by the dental follicle of alterations in alveolar bone metabolism during tooth eruption", pp.164~9 (1987)
- Yao S, "In vivo expression of RANKL in the rat dental follicle as determined by laser capture microdissection", 49, pp.451~456 (2004)
- Suzuki T, "Osteoclastogenesis during mouse tooth germ development is mediated by RANKL", 22, pp.185~191 (2004)
- Yasuda H, "Osteoclast differentiation factor is a ligand for osteoprotegrin", osteoclastogenesis-inhibitory factor and is identical to TRANCE, pp.1998, 95[DOI]
- Tay JY, "Identification of RANKL in Osteolytic lesions of the facial skeleton", 83(4), pp.349~353 (2004)
- Gotz W, "Immunohistochemical localization of receptor activator of nuclear factor kappa B(RANK) and its ligand(RANKL) in human deciduous teeth.", 71, pp.45~52 (2002)
- Yasuda H, "Identity of steoclastogenesis inhibitory factor(OCIF) and osteoprotegerin(OPG) a mechanism by which OPG", OCIF inhibits osteoclastogenesis in vitro., 1998, pp.139, 1329~1337
- Yasuda H, "A novel molecular mechanism modulating osteoclast differentiation and function", 25, pp.109~113 (1999)
- Miyamoto T, "An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factro kappaB ligand", 96, pp.4335~4343 (2000)
- Rani CS, "Dental cells express factors that reguate bone resorption", 3, pp.145~152 (2000)
- Wise GE, "Inhibition of osteoclastogenesis by the secretion of osteoprotegerin in vitro by rat dental follicle cells and its implications for tooth eruption", 47, pp.247~254 (2002)
- Mizuno A, "Transgenic mice overexpressing soluble osteoclast differentiation factor(sODF) exhibit severe osteoporosis.", 20, pp.337~344 (2002)
- Romas E, "Involvement of receptor activator of NF kappaB ligand and tumor necrosis factor-alpha in bone destruction in rhematoid arthritis", 30, pp.340~346 (2002)
- Neale SD, "Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D3 and RANKL", 27, pp.409~416 (2000)
- White SC, "Oral radiology. 4th ed,", pp.485~487 (2000), Mosby
- Jensen BL, "Craniofacial abnormalities in 52 school-age and adult patients with cleidocranial dysplasia", 13, pp.98~108 (1993)
- Tsuda E, "Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis", 234, pp.137~142 (1997)
- Simonet WS, "Osteoprotegerin:a novel secreted protein involved in the regulation of bone density", 89, pp.309~319 (1997)
- Lacey DL, "Osteoprotegerin ligand is a cytokine that regualtes osteoclast differentiation and activation", 93, pp.165~176 (1998)
- Tan KB, "Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells", 204, pp.35~46 (1997)
- Jensen BL, "Development of the dentition in cleidocranial dysplasia", 19, pp.89~93 (1990)
- Fukuta Y, "Histological and analytical studies of a tooth in a patient with cleidocranial dysostosis", 43(2), pp.85~9 (2001)
- Smith NH, "A histologic study of cementum in a case of cleidocranial dysostosis", 25, pp.470~478 (1968)
- Hitchin AD, "Cementum and other root abnormalities of permanent teeth in cleidocranial dysostosis", 139, pp.313~318 (1975)
- Choi KY, "Spatio-temporal expression patterns of Runx2 isoforms in early skeletogenesis", 34, pp.426~433 (2002)
- Ducy P, "Cbfa1 a molecular switch in osteoblast biology", 219, pp.461~471 (2000)
- Komori T, "A fundamental transcription factor for bone and cartilage", 276, pp.813~816 (2000)
- Khosla S, "Minireview:The OPG", RANKL, pp.2001, 142[DOI]
- Gori F, "The expression of osteoprotegeri n and RANK ligand and the support of osteoclast formation by stromal-osteobalst lineage cells is developmentally regulated", 141, pp.4768~4776 (2000)
- Steeve KT,, "IL-6, RANKL, TNF-alpha", IL-1:interrelations in bone resorption pathophysiology., 2004, pp.15, 49~60
- Komori T, "Runx2,a multifunctional transcription factor in skeletal development", 87, pp.1~8 (2002)